I-Mab ADR [NASDAQ: IMAB] slipped around -0.42 points on Wednesday, while shares priced at $4.18 at the close of the session, down -9.13%.
I-Mab ADR stock is now 305.83% up from its year-to-date (YTD) trading value. IMAB Stock saw the intraday high of $4.2675 and lowest of $3.2 per share. The company’s 52-week high price is 5.90, which means current price is +602.52% above from all time high which was touched on 08/15/25.
Compared to the average trading volume of 1.97M shares, IMAB reached a trading volume of 6301804 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about I-Mab ADR [IMAB]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for IMAB shares is $6.67 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on IMAB stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BTIG Research have made an estimate for I-Mab ADR shares, keeping their opinion on the stock as Buy, with their previous recommendation back on September 09, 2025. While these analysts kept the previous recommendation, Siebert Williams Shank raised their target price to Buy. The new note on the price target was released on December 09, 2021, representing the official price target for I-Mab ADR stock.
The Price to Book ratio for the last quarter was 1.68, with the Price to Cash per share for the same quarter was set at 2.09.
How has IMAB stock performed recently?
I-Mab ADR [IMAB] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -10.11. With this latest performance, IMAB shares gained by 7.46% in over the last four-week period, additionally plugging by 420.61% over the last 6 months – not to mention a rise of 391.76% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for IMAB stock in for the last two-week period is set at 51.07, with the RSI for the last a single of trading hit 0.58, and the three-weeks RSI is set at 0.52 for I-Mab ADR [IMAB]. The present Moving Average for the last 50 days of trading for this stock 3.31, while it was recorded at 4.36 for the last single week of trading, and 1.67 for the last 200 days.
I-Mab ADR (IMAB) Capital Structure & Debt Analysis
According to recent financial data for I-Mab ADR. ( IMAB), the Return on Equity (ROE) stands at -22.37%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -17.07%, reflecting the company’s efficiency in generating profits from its assets. Additionally, I-Mab ADR’s Return on Invested Capital (ROIC) is -28.33%, showcasing its effectiveness in deploying capital for earnings.
I-Mab ADR (IMAB) Efficiency & Liquidity Metrics
Based on I-Mab ADR’s (IMAB) latest financial statements, the Debt-to-Equity Ratio is 0.02%, indicating its reliance on debt financing relative to shareholder equity.
I-Mab ADR (IMAB) Efficiency & Liquidity Metrics
From an operational efficiency perspective, I-Mab ADR. (IMAB) effectively leverages its workforce, generating an average of -$1765000.0 per employee. The company’s liquidity position is robust, with a Current Ratio of 22.82% and a Quick Ratio of 22.82%, indicating strong ability to cover short-term liabilities.
Earnings analysis for I-Mab ADR [IMAB]
With the latest financial reports released by the company, I-Mab ADR posted -0.11/share EPS, while the average EPS was predicted by analysts to be reported at -0.07/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.04. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for IMAB.
Insider trade positions for I-Mab ADR [IMAB]
There are presently around $20.00%, or 25.45%% of IMAB stock, in the hands of institutional investors. The top three institutional holders of IMAB stocks are: HHLR ADVISORS, LTD. with ownership of 6.91 million shares, which is approximately 7.7935%. CALIGAN PARTNERS LP, holding 3.37 million shares of the stock with an approximate value of $$5.64 million in IMAB stocks shares; and CALIGAN PARTNERS LP, currently with $$2.3 million in IMAB stock with ownership which is approximately 1.5559%.
